X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (9) 9
index medicus (9) 9
breast neoplasms - drug therapy (7) 7
breast neoplasms - genetics (7) 7
breast neoplasms - metabolism (6) 6
female (6) 6
tamoxifen (6) 6
oncology (5) 5
animals (4) 4
breast cancer (4) 4
endocrine therapy (4) 4
estrogen (4) 4
estrogen receptor alpha - metabolism (4) 4
gene expression regulation, neoplastic - drug effects (4) 4
resistance (4) 4
antineoplastic agents, hormonal - therapeutic use (3) 3
cell biology (3) 3
estrogen receptor alpha - genetics (3) 3
expression (3) 3
mcf-7 cells (3) 3
tamoxifen - pharmacology (3) 3
tamoxifen - therapeutic use (3) 3
adult (2) 2
aged (2) 2
binding (2) 2
biomarkers, tumor - genetics (2) 2
biomarkers, tumor - metabolism (2) 2
breast neoplasms - pathology (2) 2
cells (2) 2
chip-seq (2) 2
chromatin - metabolism (2) 2
disease-free survival (2) 2
endometrial cancer (2) 2
endometrial neoplasms - drug therapy (2) 2
endometrial neoplasms - metabolism (2) 2
er-alpha (2) 2
estrogen receptor (2) 2
estrogen-receptor binding (2) 2
estrogen-receptor-alpha (2) 2
foxa1 (2) 2
gene expression regulation, neoplastic - genetics (2) 2
gene-expression (2) 2
hepatocyte nuclear factor 3-alpha - genetics (2) 2
hepatocyte nuclear factor 3-alpha - metabolism (2) 2
mice (2) 2
middle aged (2) 2
prognosis (2) 2
risk (2) 2
rna, messenger - genetics (2) 2
skin and connective tissue diseases (2) 2
transcription factors (2) 2
transcriptional regulation (2) 2
transcriptome - drug effects (2) 2
treatment outcome (2) 2
1 (1) 1
3 (1) 1
acquired endocrine resistance (1) 1
activating transcription (1) 1
activating transcription factor 2 - genetics (1) 1
activating transcription factor 2 - metabolism (1) 1
activating transcription factor-2 (1) 1
adjuvant tamoxifen (1) 1
aged, 80 and over (1) 1
alpha (1) 1
alternative splicing - physiology (1) 1
amino acid sequence (1) 1
anastrozole (1) 1
antiestrogen tamoxifen (1) 1
antineoplastic agents, hormonal - pharmacology (1) 1
aromatase inhibitors (1) 1
aromatase inhibitors - therapeutic use (1) 1
binding sites (1) 1
binding sites - genetics (1) 1
binding-sites (1) 1
biochemistry & molecular biology (1) 1
biological sciences (1) 1
biology (1) 1
biomarker selection (1) 1
biomarkers (1) 1
bone-mineral density (1) 1
breast - drug effects (1) 1
breast - metabolism (1) 1
breast cancer metastasis (1) 1
breast-cancer (1) 1
breast-cancer cells (1) 1
breast-cancer patients (1) 1
c-jun (1) 1
calcium signaling - physiology (1) 1
carcinoma (1) 1
carcinomas (1) 1
cell differentiation - physiology (1) 1
cell line, tumor (1) 1
cell proliferation - drug effects (1) 1
cell proliferation - genetics (1) 1
cell-proliferation (1) 1
cells, cultured (1) 1
chemotherapy, adjuvant (1) 1
cho cells (1) 1
chromatin (1) 1
chromatin - genetics (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Molecular Endocrinology, ISSN 0888-8809, 10/2016, Volume 30, Issue 10, pp. 1046 - 1058
Although many tissues express estrogen receptor (ER)[alpha], most studies focus on breast cancer where ER[alpha] occupies just a small fraction of its total... 
Journal Article
Cancer Research, ISSN 0008-5472, 07/2016, Volume 76, Issue 13, pp. 3773 - 3784
Journal Article
Journal Article
Molecular Oncology, ISSN 1574-7891, 11/2018, Volume 12, Issue 11, pp. 1884 - 1894
Estrogen receptor‐alpha ( ER α)‐positive breast cancer is often treated with antihormonal regimens. However, resistance to treatment is common, leading to... 
acquired endocrine resistance | 1 | FOXA | 3 | pleural effusions | GATA | breast cancer metastasis | FOXA1 | GATA3 | BIOMARKERS | ONCOLOGY | TAMOXIFEN | RESISTANCE | ALPHA | MUTATIONS | BINDING
Journal Article
Oncotarget, ISSN 1949-2553, 06/2016, Volume 7, Issue 23, pp. 33901 - 33918
Estrogen receptor alpha (ERα)-positive breast cancers are frequently treated with tamoxifen, but resistance is common. It remains elusive how tamoxifen... 
ChIP-seq | Endocrine therapy | Estrogen receptor | Neoadjuvant therapy | Gene expression analysis | gene expression analysis | CHROMATIN | estrogen receptor | PHASE-II | neoadjuvant therapy | endocrine therapy | ESTROGEN-RECEPTOR BINDING | ANASTROZOLE | CELL BIOLOGY | POSITIVE BREAST-CANCER | EVOLUTION | THERAPY | RESISTANCE | CARCINOMAS | REVEALS | Chromatin - metabolism | Predictive Value of Tests | Humans | Middle Aged | Tamoxifen - administration & dosage | Breast Neoplasms - metabolism | DNA Copy Number Variations | Patient Selection | Netherlands | MCF-7 Cells | Time Factors | Biomarkers, Tumor - metabolism | Adult | Estrogen Receptor alpha - metabolism | Female | Neoadjuvant Therapy | Transcription, Genetic | Chemotherapy, Adjuvant | Gene Expression Regulation, Neoplastic - drug effects | Precision Medicine | Cell Proliferation - genetics | Gene Expression Profiling - methods | Selective Estrogen Receptor Modulators - administration & dosage | Treatment Outcome | Gene Dosage | Hepatocyte Nuclear Factor 3-alpha - genetics | Transcriptome - drug effects | Breast Neoplasms - drug therapy | Hepatocyte Nuclear Factor 3-alpha - metabolism | Estrogen Receptor alpha - drug effects | Breast Neoplasms - genetics | Estrogen Receptor alpha - genetics | Breast Neoplasms - pathology | Protein Binding | Aged | Biomarkers, Tumor - genetics | Cell Proliferation - drug effects | Chromatin - genetics | Index Medicus
Journal Article
Breast Cancer Research and Treatment, ISSN 0167-6806, 9/2014, Volume 147, Issue 2, pp. 295 - 309
Journal Article
Proceedings of the National Academy of Sciences of the United States, ISSN 0027-8424, 02/2017, Volume 114, Issue 8, p. 1316
  The DNA-binding sites of estrogen receptor [alpha] (ER[alpha]) show great plasticity under the control of hormones and endocrine therapy. Tamoxifen is a... 
Morphology | Estrogen | Endocrine therapy | Breast cancer | Binding sites | Risk factors | Deoxyribonucleic acid--DNA
Journal Article
Journal Article
Life Science Alliance, ISSN 2575-1077, 2019, Volume 2, Issue 1, pp. e201800115 - e201800115
Chromatin immunoprecipitation (ChIP)-seq analyses of transcription factors in clinical specimens are challenging due to the technical limitations and low... 
Journal Article
Molecular Endocrinology, ISSN 0888-8809, 10/2016, Volume 30, Issue 10, pp. 1046 - 1058
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.